Skip to content

Psychedelic-assisted therapy: all studies

Page 121 of 294: studies 1,201 to 1,210 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

Von Ethnopharmakologie zur klinischen Psychedelika-Therapie — Christian Rätsch, Stanislav Grof und der Übergang zur evidenzbasierten Forschung

Zenodo (CERN European Organization for Nuclear Research) June 9, 2026 Schüller Thomas preprint

Von Ethnopharmakologie zur klinischen Psychedelika-Therapie — Christian Rätsch, Stanislav Grof und der Übergang zur evidenzbasierten Forschung billingual

DOI: 10.5281/zenodo.20617454 (opens in new tab) Field mathematics Context archaeology Interpretation philosophy

The Blind Spot of Emotional Acceptance and the Turn to System-Metacognition: The Deep Functional-Goal Observation Model as a Supplementary Link among CBT, ACT, Mindfulness, Metacognitive Therapy, Compassion-Focused Therapy, and Emotion-Focused Therapy

PhilPapers (PhilPapers Foundation) June 6, 2026 Mamoru Nagae preprint

Emotional acceptance is an important practice for recognizing anxiety, anger, appetite, the need for approval, jealousy, loneliness, procrastinatory impulses, and other internal reactions as observable experiences rather than denying or suppressing them. However, even after emotions and desires have been accepted, they may become sources of personality-level self-blame when they are identified...

Return of the sacred: Psychiatry's evolving relationship with spirituality.

Australasian Psychiatry June 5, 2026 Osama Bhatti, Mohammad Qasim Latifi

BackgroundPsychiatry has long maintained an ambivalent relationship with religion and spirituality, often acknowledging their relevance while remaining cautious about clinical engagement.ObjectivesThis article examines the historical, conceptual, and clinical tensions surrounding spirituality in psychiatry and explores how contemporary psychedelic research has renewed attention to meaning and...

MDMA-Assisted Therapy for Social Anxiety Disorder: A Randomized, Open-label, Wait-list Controlled Trial

June 4, 2026 Jason B. Luoma, M. Kati Lear, Brian Pilecki et al. preprint

Background: ±3,4-methylenedioxymethamphetamine (MDMA) has positive effects on socio-emotional processing and MDMA-Assisted Therapy (MDMA-AT) showed promise for treating SAD in a previous placebo-controlled trial. Aims: Develop a preliminary estimate of clinical response and safety for MDMA-AT versus waitlist in adults with SAD. Secondary aims included refinement of a standardized psychotherapy...

DOI: 10.31234/osf.io/a9x6d_v1 (opens in new tab) Social anxiety Randomized controlled trial Adverse effect Clinical trial +3

Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study

Translational Psychiatry June 4, 2026 Mélusine Humbert‐droz, Anna M Becker, Jan Valenta et al.

3,4-Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy (MDMA-AT) is being investigated as a treatment for several psychiatric disorders, particularly posttraumatic stress disorder. Phase 2 and 3 trials typically administered a first dose of MDMA followed by a second "booster" dose 1.5-2.5 h later, to extend the acute effect duration. However, the risks and benefits of the booster dose...

Approaches to ketamine-assisted couple therapy

Frontiers in Psychology June 4, 2026 David O. Avruch

Ketamine-assisted psychotherapy (KAP) is moving from the periphery toward the mainstream of mental healthcare. Research on the use of KAP in the context of couple therapy, however, remains limited. This phenomenological analysis sought data from psychotherapists ( n = 9), representing four different modalities of couple therapy, who are incorporating ketamine into their work with dyads....

DOI: 10.3389/fpsyg.2026.1843151 (opens in new tab) Modalities Context archaeology Mainstream Perspective graphical +11

Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.

Drugs June 4, 2026 Kevin F. Boehnke, Niloufar Pouyan, Jacob S. Aday

Chronic pain is common, costly, and for many, remains inadequately treated by existing pharmacologic and non-pharmacologic approaches. In parallel with growing dissatisfaction with conventional therapies, classic serotonergic psychedelics, such as psilocybin, lysergic acid diethylamide (LSD), ayahuasca, N,N-dimethyltryptamine (DMT), and mescaline, administered alone or within...

Insight to Action: The Role of Occupational Therapy in Psychedelic Integration

Occupational Therapy in Mental Health June 3, 2026 Gal Elkaiam, Heather Thomas, Brett Buford

Psychedelic-assisted therapy and integration are gaining renewed recognition as an effective mental health intervention. However, occupational therapy (OT) is largely missing from psychedelic integration practices despite clear overlap integration objectives. This project involved a comprehensive review of the literature, along with practitioner interviews and a survey to examine current...

DOI: 10.1080/0164212x.2026.2679671 (opens in new tab) Occupational therapy Medline Psychological therapy Perspective graphical +2

Priorities for psychedelic research among people who use psychedelics.

Journal of Psychiatric Research June 2, 2026 Daniel J. Kruger, Audrey Czerew, Leigh Farquhar et al.

Most academic psychedelic research is clinically oriented, with industry research primarily focusing on the medicalization of these substances. Given the rapid policy changes and the surge in interest among researchers and the public, it is imperative to assess and document the research priorities of the broader psychedelic community. This study aimed to identify these priorities through an...

DOI: 10.1016/j.jpsychires.2026.06.007 (opens in new tab) Full text (opens in new tab) Adverse experiences Harm reduction Psychedelics Therapy

Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults

Research Square June 2, 2026 Davis Carter, Ian Reardon, Jack Swain et al. preprint

Abstract Background Prolonged grief disorder (PGD) is a clinically distinguishable bereavement-related condition characterized by persistent yearning, identity disruption, and impaired functioning, formalized in DSM-5-TR and ICD-11 (6L72) and empirically distinguishable from but frequently co-occurring with major depressive disorder. Approximately 7 to 10 percent of bereaved adults meet...